Overview

Safety and Efficacy Study of CNOP Chemotherapy in Diffuse Large B Cell Lymphoma

Status:
Withdrawn
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Mitoxantrone Hydrochloride Liposome Injection plus Cyclophosphamide,Vincristine and Prednison(CNOP)is safe and effective in the treatment of Diffuse Large B Cell Lymphoma.
Phase:
Phase 1
Details
Lead Sponsor:
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Treatments:
Cyclophosphamide
Mitoxantrone
Prednisone
Vincristine